| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T71 |
0-46 |
Sentence |
denotes |
Referral of new patients to HITH with COVID‐19 |
| T72 |
47-147 |
Sentence |
denotes |
The role of HITH for patients with suspected or confirmed COVID‐19 is untested and likely to evolve. |
| T73 |
148-341 |
Sentence |
denotes |
Current case definition criteria should be used: patients with mild disease can go home without HITH, patients with severe disease need hospital admission, and the role of HITH lies in between. |
| T74 |
342-457 |
Sentence |
denotes |
HITH may also be a source of reassurance for people who are safe to go home but feel frightened by their diagnosis. |
| T75 |
458-556 |
Sentence |
denotes |
Referral processes: who will review, relay results and give isolation advice, in and out of hours. |
| T76 |
557-898 |
Sentence |
denotes |
Clinical criteria appropriate for HITH suggested for COVID‐19: these should be based on usual institutional HITH criteria:Requirement for ongoing assessment and/or management for moderate illness, for example, respiratory effort but not needing oxygen, decreased fluid intake, moderate secondary bacterial pneumonia requiring IV antibiotics. |
| T77 |
899-1031 |
Sentence |
denotes |
COVID‐specific modifications may be considered, for example, tolerance of fevers and/or mild hypoxia in otherwise suitable patients. |
| T78 |
1032-1196 |
Sentence |
denotes |
Monitoring those at higher risk of deterioration: those with respiratory/cardiac/oncological co‐morbidities, neonates and elderly should be considered individually. |
| T79 |
1197-1332 |
Sentence |
denotes |
Duration of HITH admission: symptoms should be clearly improving before discharge; deterioration may occur beyond day 5 of the illness. |
| T80 |
1333-1548 |
Sentence |
denotes |
Additional interventions that may increase use of HITH: depending on HITH capability: equipment kits for patient self‐observation, nasogastric/intravenous hydration, oxygen using concentrators and remote monitoring. |
